PGLYRP4 and bacterial infectious disease with sepsis: In contrast to this well-known canonical function, PGLYRP4 has been conclusively demonstrated to display significant inhibitory effects on the expression of pro-inflammatory mediators and tight junction genes, which attenuates host inflammatory defense, and phagocyte recruitment and activation in the lung result in impaired clearance of bacteria and subsequent bacteremia during pneumococcal pneumonia [82].